Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P-type calcium channels are voltage-gated calcium channels (VGCCs) primarily located in neurons within the central and peripheral nervous systems. They mediate calcium influx upon membrane depolarization, which is essential for neurotransmitter and hormone release at synaptic terminals. Mutations in the gene encoding the P-type calcium channel α1 subunit (CACNA1A) are linked to several neurological disorders. P-type channels are selectively blocked by ω-agatoxin IVA.
ω-agatoxin IVA selectively blocks P-type calcium channels, preventing calcium influx and subsequent neurotransmitter/hormone release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P-type Calcium Channel (None).